Quantum Biopharma (QNTM) Depreciation & Amortization (IS) (2019 - 2026)
Quantum Biopharma recorded quarterly Depreciation & Amortization (IS) of $127436.0 in Q1 2026, down 1.5% quarter-over-quarter from $129371.0 in Q4 2025, and down 1.74% year-over-year from $129690.0 in Q1 2025.
Quantum Biopharma's Depreciation & Amortization (IS) history runs 8 years deep, the most recent figure standing at $127436.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (IS) fell 1.74% year-over-year to $127436.0; the TTM figure through Mar 2026 stood at $543526.0 (up 7.11% YoY), while the FY2025 annual figure was $545780.0, up 11.25% from the prior year.
- Depreciation & Amortization (IS) came in at $127436.0 for Q1 2026 at Quantum Biopharma, down from $129371.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (IS) ranged from a high of $1.1 million in Q1 2023 to a low of $120141.0 in Q1 2024.
- A 5-year average of $295752.0 and a median of $133251.5 in 2024 frame the typical range for Depreciation & Amortization (IS).
- Across the five-year window, Depreciation & Amortization (IS) tumbled 89.37% in 2024 and increased 20.3% in 2025, its largest moves.
- Quantum Biopharma's Depreciation & Amortization (IS) stood at $1.1 million in 2022, then tumbled by 86.67% to $146810.0 in 2023, then fell by 18.17% to $120141.0 in 2024, then rose by 7.68% to $129371.0 in 2025, then decreased by 1.5% to $127436.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (IS) over the past three periods registered $127436.0, $129371.0, and $145336.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 127,436.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127,436.00 |
| Dec 31, 2025 | 129,371.00 |
| Sep 30, 2025 | 145,336.00 |
| Jun 30, 2025 | 141,383.00 |
| Mar 31, 2025 | 129,690.00 |
| Dec 31, 2024 | 120,141.00 |
| Sep 30, 2024 | 120,814.00 |
| Jun 30, 2024 | 136,813.00 |
| Mar 31, 2024 | 120,141.00 |
| Sep 30, 2023 | 146,810.00 |
| Mar 31, 2023 | 1.13 Mn |
| Mar 31, 2022 | 1.10 Mn |
| Jun 30, 2021 | 982,353.00 |
| Sep 30, 2020 | 964,421.24 |
| Jun 30, 2020 | 717,119.77 |
| Mar 31, 2020 | 724,510.54 |
| Dec 31, 2019 | 1.41 Mn |